A company creating extended-release delivery techniques for eye therapies is raising $11.9 million in its first venture funding round. . . . → Read More: Sustained-Released Eye Treatment Company Raises $11.9M
|
|||||
       
 |
Results of a clinical trial reveal an optimal dose for an insulin capsule that in 12 weeks reduces blood glucose levels in patients with type 2 diabetes. . . . → Read More: Trial Shows Insulin Capsules Reduce Blood Glucose Levels 
A developer of remote health tracking technology says the Food and Drug Administration cleared its continuous patient monitoring system for clinical use. . . . → Read More: FDA Clears Digital Health Monitoring System 
The first participant in a clinical trial received an experimental drug to treat patients with depression that express high levels of a stress-related protein. . . . → Read More: Biomarker-Guided Depression Drug Trial Underway 
A project to develop a brain-computer device to stimulate upper and lower limb movement in people with spinal cord injuries is receiving a €3.7 million award. . . . → Read More: Grant Funds Implanted Brain-Computer Spinal Injury Device 
More than 133 million people have diabetes, nearly one-third of the world’s total, yet almost half of the world’s diabetes drug sales volume is in the U.S. . . . → Read More: Infographic – U.S. Dominates Diabetes Drug Sales 
A company building a therapy and technology network for improving access to mental health providers is raising $15 million in its first venture round. . . . → Read More: Mental Health Therapy, Tech Network Gains Early Funds 
A developer of cancer treatments triggered by tumor chemistry is partnering with biologic drug maker Regeneron on dual-action cancer immunotherapies. . . . → Read More: Biotech, Regeneron in $2B Cancer Antibody Deal 
A start-up enterprise developing personalized liquid biopsies for finding residual cancer in patients is beginning work and raising $56 million in venture funds. . . . → Read More: Residual Cancer Detection Company Launches, Raises $56M  Comments are closed  Finance, New products  biomedical, cancer, clinical trials, engineering, entrepreneurs, equity, genomics, investment, life sciences, medical device, university, venture capital 
A start-up enterprise seeks to make drugs for treating rare diseases more readily available to physicians and patients in Europe. . . . → Read More: Company to Boost Orphan Drugs in Europe Comments are closed Intellectual property, New products, Regulations biomedical, economics, entrepreneurs, Europe, licensing, life sciences, pharmaceuticals |
||||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||